Despite recent performance challenges, JPMorgan U.S. Equity (including two European vehicles, a Canadian exchange-traded fund, a separate account, and two collective investment trusts) benefits from a solid team and a disciplined, risk-conscious approach.
Recent results have been difficult for investors to overlook. From August 2025 through September 2026, the institutional share class gained 9.3% annualized, significantly trailing the prospectus S&P 500 benchmark's 18.9% return and ranking in the bottom quartile of the large-blend Morningstar Category. The disappointing stretch has also weighed on the strategy's longer-term record. Performance has been hindered by a unique market environment in which artificial intelligence-related themes drove outsize gains in key areas such as memory semiconductors, while growing uncertainty around the long-term prospects of other areas like software created additional headwinds. Even so, investors should consider further patience as the strategy retains several notable strengths.
The investment process remains a key advantage. Managers Scott Davis and David Maccarrone oversee a concentrated portfolio of roughly 50 to 70 stocks that is differentiated from the benchmark while maintaining diversified risk characteristics. Working closely with analysts, the managers look beyond traditional sector classifications to identify stocks with the most attractive risk/reward profiles. The portfolio is constructed to maintain benchmark-like exposure across underlying risk factors. This thoughtful design goes beyond the more common approach of aggregating analysts' highest-conviction ideas, and the managers devote significant attention to stocks they do not own, resulting in a portfolio that is both intentional and carefully balanced.
The strategy also remains in capable hands despite a recent leadership change. Comanager Shilpee Raina departed the firm on Sept. 1, 2026, and Maccarrone was named comanager to assume her responsibilities. Maccarrone has more than 30 years of experience and currently serves as the associate director of research. Davis, a named manager since 2014, provides important continuity. Together, they draw on the insights of the firm’s solid, core research team.
While recent performance has been disappointing, the strategy's experienced leadership and differentiated portfolio-construction process give it a strong foundation for improved results.